Life Science REIT (LON:LABS) Stock Rating Reaffirmed by Shore Capital
Shore Capital reiterated their buy rating on shares of Life Science REIT (LON:LABS – Free Report) in a research note published on Thursday morning, Marketbeat reports. Separately, Jefferies Financial Group decreased their price objective on Life Science REIT from GBX 45 ($0.60) to GBX 36 ($0.48) and set a hold rating on the stock in […]
30 Sep 05:22 · The Markets Daily